--- title: "Niagen Bioscience (NAGE.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/NAGE.US/norm.md" symbol: "NAGE.US" name: "Niagen Bioscience" parent: "https://longbridge.com/en/quote/NAGE.US.md" datetime: "2026-03-04T13:07:12.515Z" locales: - [en](https://longbridge.com/en/quote/NAGE.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/NAGE.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/NAGE.US/norm.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NAGE.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NAGE.US/norm.md) # Niagen Bioscience (NAGE.US) — Financial Reports ## Income Statement (USD) | Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | EPS | 0.0500 | 0.0400 | 0.0600 | 0.0864 | 0.0200 | | ROE | 27.15% | 24.15% | 39.93% | 71.38% | 23.08% | | Revenue | 33.99M | 31.12M | 30.48M | 29.13M | 25.58M | | Net income | 4.58M | 3.61M | 5.06M | 7.18M | 1.88M | | Operating income | 4.24M | 3.19M | 4.77M | 7.11M | 1.60M | | Gross margin | 64.52% | 65.00% | 63.42% | 62.48% | 63.49% | | Net margin | 13.47% | 11.60% | 16.61% | 24.65% | 7.34% | | Profit quality | 114.73% | 254.80% | 60.54% | 82.85% | 45.84% | ## Balance Sheet (USD) | Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 98.14M | 91.53M | 81.34M | 68.28M | 56.52M | | Leverage | 1.39 | 1.43 | 1.47 | 1.48 | 1.64 | | BVPS | 0.8843 | 0.8049 | 0.7041 | 0.5948 | 0.4511 | | Turnover | 1.61 | 1.60 | 1.59 | 1.62 | 1.67 | | Cash & STI | 64.14M | 60.32M | 55.46M | 44.51M | 32.25M | | Inv & Rec | 18.79M | 14.41M | 11.19M | 9.19M | 10.54M | | LT assets | 3.86M | 4.16M | 4.34M | 3.45M | 3.62M | | Net debt | -61.08M | -57.03M | -51.94M | -41.86M | -29.35M | ## Cash Flow Statement (USD) | Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | 3.69M | 1.25M | 7.88M | 8.58M | 3.50M | | Investing CF | -24000.00 | -135000.00 | -32000.00 | -69000.00 | -21000.00 | | Financing CF | 148000.00 | 3.74M | 3.10M | 3.75M | 1.04M | | Free CF | 1.82M | -588375.00 | 6.00M | 6.05M | 3.38M | | OCF coverage | 13185.71% | 905.80% | 22522.86% | 12088.73% | 7766.67% | | Repaid & issued | - | - | - | - | - | | CapEx | -24000.00 | -135000.00 | -32000.00 | -69000.00 | -41000.00 |